Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from JJ.

3 Dividend Stocks to Buy for a Safe Haven in This Volatile Market

The consistency in their dividend payments makes them dependable stocks in a volatile market.

Barchart

Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out

Protagonist Therapeutics broke out Monday after the company's drug topped its rival from Bristol in a psoriasis study.

Investors Business Daily

Johnson & Johnson begins battle over baby powder’s ‘link to cancer’ in $10 billion case

Courts have rejected J&J’s two previous efforts to resolve the talc litigation

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Slush Puppie’s Parent Hits 52-Week Low. Time to Buy?

J&J Snack Foods, the maker of food and beverage brands such as Slush Puppie, SuperPretzel, and Hola Churros, hit a 52-week low on Tuesday, its 14th in the past 12 months. Here’s why it’s time to buy.

Barchart

Thousands to sue Johnson & Johnson in UK over alleged talc link to cancer

Group action with 3,500 claimants alleges company knew its talcum powder products contained dangerous asbestos

The Guardian - UK

2 Dividend Kings You Should Snap Up Immediately

Recent earnings from these dividend-paying companies reflects their stability.

Barchart

How tech leaders are rethinking their cloud strategies in the face of fast-rising costs

As spending on cloud computing rises sharply amid the generative AI boom, executives are on the hunt for cost savings.

Fortune

Read news from The Economist, FT, and more,
with one subscription

J&J Skids After Dow Giant Beat Earnings Views, But 'Prudent' Guidance Disappoints

Johnson & Johnson stock gapped down Wednesday after the health care giant issued light 2025 sales guidance, taking a hit from exchange rates.

Investors Business Daily

J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders

Johnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by purchasing Intra-Cellular Therapies

The Independent UK

J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug

Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies.

Investors Business Daily

J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

Investors Business Daily

‘I felt betrayed’: Woman blames cancer diagnosis on talcum powder use

Exclusive: Jane Campbell is one of thousands of women in the UK planning legal action against one of the world’s largest pharmaceutical firms over alleged links between talc and cancer

The Independent UK

FDA proposes new testing rules to ensure cosmetics are asbestos-free

The Food and Drug Administration is proposing a rule that cosmetic companies would have to take extra steps to ensure that any products containing talc are free of asbestos

The Independent UK

Burning Concerns: New Study Links Scented Candles to Increased Cancer Risks

Recent studies show scented candles may emit harmful substances that can lead to respiratory problems and cognitive decline.

International Business Times UK

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Johnson & Johnson Risks UK Lawsuit Over Talc Cancer Claim

UK claimants announced Wednesday legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.

Evening Standard

Thousands of women plan legal action over alleged links between talc and cancer

If the action goes ahead it is understood to be the first of its kind against Johnson & Johnson in the UK.

The Guardian - US

Same-sex couple calls for protest after Washington eatery refuses to cater their wedding

JJ’s owner tells Rayah Calkins and fiancee Lillian Glover that the restaurant ‘stands by one thing only – the word of God’

Investors Business Daily

Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review

The Dow and S&P 500 hit record highs as the stock market rally extended its weekly win streak with modest gains.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

J&J Stock Leapfrogs 50-Day Line After Health Care Titan Raises Sales Outlook

Johnson & Johnson stock rose Tuesday after the company beat Wall Street's third-quarter expectations, but cut its full-year profit forecast.

Top News

Johnson & Johnson Subsidiary Files For Bankruptcy For Third Time

Johnson & Johnson subsidiary files for bankruptcy to settle talc-related cancer lawsuits. Proposed billion settlement faces legal challenges.

International Business Times

J&J CEO Slams Biden's Drug Pricing Law, Says It Will 'Chill' Innovation

J&J CEO explained that the new drug-price negotiation law threatens development of new drugs, according to Bloomberg.

International Business Times

Johnson & Johnson To Add $1.1 Billion To Proposed Talc Settlement

Johnson & Johnson would be adding $1.1 billion to its talc settlement proposal.

Barchart

How High Can This Healthcare Stock Soar With Nvidia's Help?

Dividend King J&J can boost its MedTech business with Nvidia’s help.

Zenger

Johnson & Johnson Acquires V-Wave For $1.7 Billion To Boost Heart Failure Treatment Portfolio‌ ‌

J&J's strategic move aims to strengthen its position in the congestive heart failure market, foreseeing significant growth ahead.‌ ‌

Investors Business Daily

CrowdStrike: What's Ahead For Cybersecurity Player In The Wake Of Its Corporate Crisis

After it botched a cybersecurity software update and slammed customers, CrowdStrike stock is paying the price. A crisis management challenge lies ahead.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.